ArticleExperimental & molecular medicine2025

Multiomic quantification of the KRAS mutation dosage improves the preoperative prediction of survival and recurrence in patients with pancreatic ductal adenocarcinoma.

Won-Gun Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.